Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pedro L.S. Uson"'
Autor:
Niloy Jewel Samadder, Luke Mountjoy, Blanca Lizaola-Mayo, Michael A. Golafshar, Tanio S. Bekaii-Saab, Katie L. Kunze, Douglas L. Riegert-Johnson, Harminder Singh, Suryakanth R. Gurudu, Neej J. Patel, Pedro L.S. Uson, Margaret Klint, Lisa A. Boardman, John B. Kisiel, Jeremy Clifton Jones, Jonathan A. Leighton, Daniel H. Ahn, Mohamad Bassam Sonbol, A. Keith Stewart, Ed D. Esplin, Mitesh J. Borad, Robert L. Nussbaum
Publikováno v:
Clinical Gastroenterology and Hepatology. 20:e508-e528
Background & Aims Hereditary factors play a role in the development of colorectal cancer (CRC). Identification of germline predisposition can have implications on treatment and cancer prevention. This study aimed to determine the prevalence of pathog
Autor:
Aradhana Kasimsetty, Elzbieta Lenkiewicz, James M Bogenberger, Jan B. Egan, Bolni Marius Nagalo, Smriti Malasi, Mitesh J. Borad, Pedro L.S. Uson, Heidi E. Kosiorek, Jennifer L. Leiting, Marcela Salomao, Amro M. Abdelrahman, Mark J. Truty, Mansi Arora, Michael T. Barrett, Esteban Braggio, Yumei Zhou, Xianfeng Chen
Publikováno v:
Cancer Chemotherapy and Pharmacology. 85:1063-1078
NUC1031 is a first-in-class ProTide, that is a gemcitabine pro-drug designed to overcome putative mechanisms of resistance, including decreased expression of hENT/hCNT transporters, absence of activating enzymes such as deoxycytidine kinase (dCK) and
Autor:
Tanios Bekaii-Saab, Katie L. Kunze, Niloy Jewel Samadder, Keith Stewart, Robert L. Nussbaum, Jonathan A. Leighton, Pedro L.S. Uson, Ed D. Esplin, Michael A. Golafshar, Daniel H. Ahn, Mohamad Bassam Sonbol, Douglas L. Riegert-Johnson, Mitesh J. Borad, Lisa A. Boardman, Suryakanth R. Gurudu
Publikováno v:
Molecular Genetics and Metabolism. 132:S34-S35
Autor:
Douglas O. Faigel, N. Jewel Samadder, Daniel H. Ahn, Margaret Klint, A. Keith Stewart, Edward D. Esplin, Tanios Bekaii-Saab, Mitesh J. Borad, Norio Fukami, Mohamad Bassam Sonbol, Katie L. Kunze, Douglas L. Riegert-Johnson, Robert L. Nussbaum, Lisa A. Boardman, Rahul Pannala, Michael A. Golafshar, Pedro L.S. Uson
Publikováno v:
Clinical and Translational Gastroenterology
Introduction To report the prevalence and outcomes of unselected pancreatic cancer (PC) patients with pathogenic/likely pathogenic germline variants (PGVs) detected using a universal testing approach. Methods We undertook a prospective, multisite stu
Autor:
Eduardo A. Rodriguez, Michael Lehrer, Cindy Azevedo, Michael A. Golafshar, Natalie Ertz-Archambault, Blanca Lizaola-Mayo, Sarah K. Macklin-Mantia, Lisa A. Boardman, Tanios Bekaii-Saab, Richard R. Sharp, Luke Mountjoy, C.S. Thorpe, Pedro L.S. Uson, Megan M. Hager, Nathan Y. Yu, Katie L. Kunze, Scott H. Okuno, Douglas L. Riegert-Johnson, Aleksandar Sekulic, Margaret Klint, Robert L. Nussbaum, Deborah J. Rhodes, Edward D. Esplin, N. Jewel Samadder, Alan H. Bryce, Myra J. Wick, Neej J. Patel, A. Keith Stewart
Publikováno v:
JAMA Oncology. 7:230
Importance Hereditary factors play a key role in the risk of developing several cancers. Identification of a germline predisposition can have important implications for treatment decisions, risk-reducing interventions, cancer screening, and germline